ASTEX PHARMACEUTICALS & Design — 1573075
Application number
1573075
Registration number
TMA1055074
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2012-04-13
Registered
2019-09-18
Registration Expiry Date
2029-09-18
Current owner
Astex Therapeutics Limited
436 Cambridge Science Park
Milton Road
Cambridge, CB4 0QA
UNITED KINGDOM
Agent
GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5
Registered Owner
Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, CA 94588
UNITED STATES OF AMERICA
Applicant
Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, CA 94588
UNITED STATES OF AMERICA
Documents
Index headings
- A ASTEX PHARMACEUTICALS
- AZTECS
Vienna information (Code & Description)
- 1.13.1
- Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models
- A 1.13.15
- Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixes
- 26.4.4
- Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners
- A 26.4.5
- One quadrilateral
- A 26.4.14
- Quadrilaterals containing representations of human beings or parts of the human body
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
- 27.3.1
- Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object
- A 27.3.2
- Letters or numerals representing a human being or a part of the human body
Goods (Nice class & Statement)
- (1) Chemicals, chemical compounds and chemical preparations for non-medical purposes, namely, those for use in biotechnology; chemicals, chemical compounds and chemical preparations for medical research purposes, namely, those for use in drug discovery and the manufacture or development of pharmaceuticals; diagnostic preparations and/or reagents for clinical or medical laboratory use; pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, oncological diseases and disorders, neurological and central nervous system diseases and disorders, namely Alzheimer's disease, Parkinson's disease, Huntingdon's disease, AIDS-related dementia, amyotrophic lateral sclerosis, cerebral palsy, brain injury, stroke, spinal cord injury, ischemia, ischemic injury, reperfusion injury, organ injury in transplant, seizure disorders, epilepsy, retinitis pigmentosa, spinal muscular atrophy, and cerebellar degeneration, dermatological diseases and disorders, namely eczema, alopecia, basal cell carcinoma, melanoma, psoriasis, and skin cancer, hematological diseases and disorders, namely leukemia, lymphoma, hypereosinophilic syndrome, myeloprofliferative disorders, myeloproliferative syndrome, myelodysplastic syndrome, promyelocytic leukemia, chronic anemia, and aplastic anemia, bone diseases and disorders, respiratory diseases and disorders, endrocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, namely hyperthyroidism, hypothyroidism, thyroid cancer, pituitary cancer, hormone therapy in cancer, and hormone sensitive tumours, diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders, namely asthma, alopecia, systemic lupus erythematosus, autoimmune mediated glomerulonephritis, rheumatoid arthritis, psoriasis, inflammatory bowel disease, automimmune diabetes mellitus, organ transplant rejection, autoimmune diseases, immunologic deficiency syndromes, and immunotherapy in cancer, allergic reactions, metabolic disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, obesity, hyperthyroidism, hypothyroidism, and tumour metabolism, ocular disorders and pain; pharmaceuticals, namely, anti-inflammatory agents and anti-infectives; computer software that enables users to manipulate and display data in the fields of drug discovery, biotechnology research, and scientific analysis.
- (2) Chemicals, chemical compounds and chemical preparations and products including those for use in biotechnology and drug discovery; chemicals, chemical compounds and chemical preparations and products for use in the manufacture and/or development of antivirals and pharmaceuticals for use in oncology; Pharmaceuticals for use in oncology; chemicals for use in medical research; diagnostic preparations and/or reagents for clinical or medical laboratory use; antiviral drugs and antiviral pharmaceuticals; chemicals for medical use for use in oncology; chemicals for use as antivirals; computer software that enables users to create, organize, manipulate, display, transmit, store and retrieve data in the fields of drug discovery, biotechnology research, and scientific analysis.
Services (Nice class & Statement)
(1) Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development; providing health care information via telephone and the Internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.
(2) Drug discovery and development services; biotechnology research; providing medical and scientific information in the field of pharmaceuticals and clinical trials; providing health care information via telephone and the Internet; providing information concerning diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.
(3) Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.
Classification data
Disclaimer
The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.
- 1 - Chemicals and adhesives
- 5 - Pharmaceuticals and herbicides
- 9 - Electrical, scientific and teaching apparatus and software
- 42 - Computer and scientific
- 44 - Medical and veterinary, beauty, agricultural and forestry
Claims
- Priority Filing Date: October 13, 2011, Country or Office: UNITED STATES OF AMERICA, Application No. 85446654 in association with the same kind of goods (1) and in association with the same kind of services (1)
- Used in UNITED STATES OF AMERICA on services (3)
- Registered in or for UNITED STATES OF AMERICA on August 06, 2013, under No. 4381344 on services (3)
- Proposed Use in CANADA on goods and on services (1),(2)
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-12-28 DATE OF CHANGE / DATE DE CHANGEMENT: 2023-12-15 COMMENTS / COMMENTAIRES: FROM/DE: Astex Pharmaceuticals, Inc. TO/A: Astex Therapeutics LimitedAction History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2012-04-13 | ||
| Created | 2012-04-13 | ||
| Formalized | 2012-04-24 | ||
| Search Recorded | 2012-11-05 | ||
| Examiner's First Report | 2012-11-05 | 2013-05-05 | |
| Extension of Time | 2013-05-09 | 2013-11-05 | Request Letter Date: 2013/04/29 |
| Approval Notice Sent | 2014-01-14 | 2014-02-11 | |
| Approved | 2014-03-06 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2014-03-26 | Vol.61 Issue 3100 | |
| Allowed | 2014-07-11 | ||
| Allowance Notice Sent | 2014-07-11 | 2015-04-13 | |
| Extension of Time | 2015-03-10 | 2015-10-13 | Online Request Date: 2015/03/10 |
| Rep for Service Changed | 2015-04-14 | From: 6237 To: 32 / Voir Preuve au dossier/See evidence on File No. 1153405 | |
| Agent Changed | 2015-04-14 | From: 6237 To: 32 / Voir Preuve au dossier/See evidence on File No. 1153405 | |
| Amendment to Application | 2015-04-14 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 1153405 | |
| Rep for Service Changed | 2015-05-14 | From: 32 To: 6237 / Voir Preuve au dossier/See evidence on File No. 1573073 | |
| Agent Changed | 2015-05-14 | From: 32 To: 6237 / Voir Preuve au dossier/See evidence on File No. 1573073 | |
| Extension of Time | 2015-09-09 | 2016-04-13 | Online Request Date: 2015/09/09 |
| Extension of Time | 2016-03-10 | 2016-10-13 | Online Request Date: 2016/03/10 |
| Extension of Time | 2016-09-19 | 2017-10-13 | Online Request Date: 2016/09/19 |
| Extension of Time | 2017-09-12 | 2018-10-13 | Request Letter Date: 2017/08/29 |
| Extension of Time | 2018-10-04 | 2019-10-13 | Request Letter Date: 2018/09/20 |
| Registered | 2019-09-18 | 2029-09-18 | |
| Agent Changed | 2023-12-28 | From/De: 6237 To/A: 32 | |
| Change of Title Registered | 2023-12-28 | Assignment/Cession |